Charles Li
Director/Board Member en EKSO BIONICS HOLDINGS, INC. .
Fortuna: 37 275 $ al 31/03/2024
Perfil
Charles Li is currently an Independent Director at Ekso Bionics Holdings, Inc. and the Chief Business Officer at Angel Pharmaceuticals Co., Ltd.
He holds a doctorate degree from Harvard University and an undergraduate degree from Xi'an Jiaotong University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/04/2023 | 27 408 ( 0.15% ) | 37 275 $ | 31/03/2024 |
Cargos activos de Charles Li
| Empresas | Cargo | Inicio |
|---|---|---|
| EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 11/03/2018 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 10/10/2020 |
Formación de Charles Li.
| Harvard University | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EKSO BIONICS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Charles Li
